Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

LeMaitre Vascular, Inc. - Common Stock (NQ:LMAT)

92.64 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about LeMaitre Vascular, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Astrana Health, Privia Health, Illumina, Waters Corporation, and LeMaitre Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading. 
Via StockStory
Topics Economy
Why LeMaitre (LMAT) Stock Is Down Today
Shares of medical device company LeMaitre Vascular (NASDAQ:LMAT) fell 2.2% in the afternoon session after the stock traded lower amid broader market weakness. U.S. stock markets began September trading... 
Via StockStory
Topics Bonds Stocks World Trade
LMAT Q2 Deep Dive: International Expansion and Product Momentum Drive Upbeat Outlook
Medical device company LeMaitre Vascular (NASDAQ:LMAT) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 15% year on year to $64.23 million. Guidance for next... 
Via StockStory
Earnings Scheduled For August 5, 2025
 
Via Benzinga
Earnings Scheduled For May 1, 2025
 
Via Benzinga
Earnings Scheduled For February 27, 2025
 
Via Benzinga
Why LeMaitre (LMAT) Stock Is Trading Up Today
Shares of medical device company LeMaitre Vascular (NASDAQ:LMAT) jumped 9.5% in the afternoon session after the company reported better-than-expected second-quarter financial results and raised its... 
Via StockStory
Topics ETFs Stocks World Trade
LeMaitre (LMAT) Q2 Revenue Jumps 15%
Via The Motley Fool
LeMaitre (NASDAQ:LMAT) Exceeds Q2 Expectations, Full-Year Sales Guidance is Optimistic
Medical device company LeMaitre Vascular (NASDAQ:LMAT) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 15% year on year to $64.23 million. Guidance for next quarter’s... 
Via StockStory
LeMaitre (LMAT) Reports Q2: Everything You Need To Know Ahead Of Earnings
Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be reporting results this Tuesday after market close. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
LEMAITRE VASCULAR INC (NASDAQ:LMAT) – A Quality Stock Worth Considering
LEMAITRE VASCULAR INC (NASDAQ:LMAT) shows strong growth, high profitability, and solid financial health, making it a candidate for quality investors. The stock meets key criteria with a 31.7% ROIC and... 
Via Chartmill
Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned... 
Via StockStory
Topics ETFs Stocks World Trade
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
New Directors Bring Extensive NASDAQ Expertise Across Legal, Operational and Corporate Leadership Capacities 
From Anteris Technologies Global Corp.
Via GlobeNewswire
Intuitive Surgical (NASDAQ:ISRG): Strongest Q1 Results from the Surgical Equipment & Consumables - Specialty Group
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Intuitive Surgical... 
Via StockStory
Topics Artificial Intelligence Economy
LMAT Q1 Earnings Call: Sales Growth Outpaces Expectations, Margin Pressures Addressed
Medical device company LeMaitre Vascular (NASDAQ:LMAT) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 12% year on year to $59.87 million. The company expects next quarter’s revenue... 
Via StockStory
Topics World Trade
1 Cash-Heavy Stock That Stand Out and 2 to Question
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
Q1 Earnings Highs And Lows: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Let’s dig into the relative performance of LeMaitre (NASDAQ:LMAT) and its peers as we unravel the now-completed Q1 surgical equipment & consumables - specialty earnings season. 
Via StockStory
Topics Artificial Intelligence Economy
Why LeMaitre (LMAT) Shares Are Sliding Today
Shares of medical device company LeMaitre Vascular (NASDAQ:LMAT) fell 12.2% in the afternoon session after the company reported weak first quarter 2025 results with a significant miss on full-year EPS... 
Via StockStory
Topics Artificial Intelligence
LeMaitre’s (NASDAQ:LMAT) Q1: Beats On Revenue, Guides for Strong Full-Year Sales
Medical device company LeMaitre Vascular (NASDAQ:LMAT) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 12% year on year to $59.87 million. Guidance for next... 
Via StockStory
A Look at LeMaitre Vascular's Upcoming Earnings Report
 
Via Benzinga
Earnings To Watch: LeMaitre (LMAT) Reports Q1 Results Tomorrow
Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be reporting results tomorrow after the bell. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence World Trade
1 Profitable Stock with Impressive Fundamentals and 2 to Steer Clear Of
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at LeMaitre (NASDAQ:LMAT) and the best and... 
Via StockStory
Topics Artificial Intelligence Economy
3 Healthcare Stocks Facing Headwinds
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
Via StockStory
Topics Stocks
Spotting Winners: Teleflex (NYSE:TFX) And Surgical Equipment & Consumables - Specialty Stocks In Q4
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - specialty stocks fared in... 
Via StockStory
Topics Artificial Intelligence Economy
Why LEMAITRE VASCULAR INC (NASDAQ:LMAT) qualifies as a quality stock.
A fundamental analysis of (NASDAQ:LMAT): Why Quality Investors May Find LEMAITRE VASCULAR INC (NASDAQ:LMAT) Attractive. 
Via Chartmill
2 Reasons to Avoid LMAT and 1 Stock to Buy Instead
Over the past six months, LeMaitre’s shares (currently trading at $83.18) have posted a disappointing 10.5% loss while the S&P 500 was down 4.1%. This may have investors wondering how to approach the... 
Via StockStory
Topics Stocks Supply Chain
Winners And Losers Of Q4: Integra LifeSciences (NASDAQ:IART) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Looking back on surgical equipment & consumables - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Integra LifeSciences (NASDAQ:IART) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
Q4 Earnings Review: Surgical Equipment & Consumables - Specialty Stocks Led by Intuitive Surgical (NASDAQ:ISRG)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Intuitive... 
Via StockStory
Topics Artificial Intelligence Economy
LeMaitre (NASDAQ:LMAT) Misses Q4 Sales Targets, Stock Drops 11%
Medical device company LeMaitre Vascular (NASDAQ:LMAT) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 14% year on year to $55.72 million. Next quarter’s revenue guidance of... 
Via StockStory
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS